Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03404609 : Rapid Non-Invasive Brain Stimulation for OCD (oTMS)
PhasePhase 2
AgesMin: 18 Years Max: 65 Years
Eligibility
Inclusion Criteria:

- Age 18-65

- Primary diagnosis of OCD

- Sufficient severity of OCD symptoms

- Capacity to provide informed consent

Exclusion Criteria:

- Psychiatric or medical conditions or medications that make participation unsafe

- Pregnant or nursing females

- Previous exposure to TMS or ECT

- History of any implanted device or psychosurgery

- Presence of metallic device or dental braces
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03404609      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740